A LinkedIn post from Single Quantum highlights the company’s planned presence at the Focus on Microscopy 2026 conference in Stockholm. According to the post, Lead Application Engineer Hein Zijlstra is scheduled to present on how its superconducting nanowire single-photon detectors, or SNSPDs, can extend bio-imaging into the near-infrared for deep tissue applications.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes that Single Quantum intends to showcase a microscopy solution at Booth 30 that combines its photon detection technology with a PicoQuant microscope. This combination is described as enabling high sensitivity and time resolution across visible, NIR and SWIR ranges for fluorescence lifetime imaging, suggesting a focus on high‑end research and clinical imaging markets.
For investors, the conference participation and technical presentation may signal continued efforts to position Single Quantum as a specialist provider in advanced photonics and bio-imaging. Visibility at a focused scientific event and association with PicoQuant could support future commercial partnerships, though the post does not reference any specific revenue, contracts or timelines.
The emphasis on NIR and SWIR capability points to potential relevance in fast-growing segments such as biomedical imaging, quantum optics and precision diagnostics. If the showcased solution gains traction with research institutions and equipment manufacturers, it could strengthen the company’s competitive positioning in niche, high-value instrumentation markets over the medium term.